Comparison with randomized controlled trials as a strategy for evaluating instruments in Mendelian randomization

Int J Epidemiol. 2020 Aug 1;49(4):1404-1406. doi: 10.1093/ije/dyz236.

Authors

Dipender Gill¹, Venexia M Walker^{2

3}, Richard M Martin^{2

3}, Neil M Davies^{2

3}, Ioanna Tzoulaki^{1

4}

Affiliations

¹ Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
² Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
³ Bristol Medical School Population Health Sciences, University of Bristol, Bristol, UK.
⁴ Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.

PMID: 31764983
DOI: 10.1093/ije/dyz236

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antihypertensive Agents*
Drug-Related Side Effects and Adverse Reactions*
Humans
Mendelian Randomization Analysis
Randomized Controlled Trials as Topic

Substances

Antihypertensive Agents

Grants and funding